Skip to end of metadata
Go to start of metadata

NIF is developing annotation standards for neuroscience-relevant data and databases to make it easier to search across and integrate data from multiple sources.  For our perspective on why such standards are needed, please read our blog .  Our motto in the creation of these standards is "arbitrary but defensible", i.e., we will never be able to develop a standard that is 100% agreed upon but it should be based on a set of clearly defined and well reasoned criteria.  As the NIF project is built upon a unified semantic framework based on the NIFSTD ontologies and Neurolex lexicon, all standards will be defined according to these ontologies. However, NIF is moving beyond simple mapping of content to providing a more consistent user experience for navigating among very heterogeneous data sources.  The more we can do to make sources look and "behave" the same, the better we serve our users. 

Column order

All sources should look and "act" the same to the extent possible.  Thus, each view through the NIF should adhere to a consistent set of guidelines for creating these views.  The order of columns should be uniform and all services and views should adhere to these standards. The order of the columns should generally follow the same format so that users have a consistent experience when they change from source to source.  Obviously, the exact number of columns will change depending on the source.

  1. Column 1:  Source database and link to source database if appropriate
  2. Column 2:  Most important entity, i.e., what the database is offering or about:  gene, anatomical structure
  3. Column 3:  Additional entities in order of descending granularity, e.g., anatomical structure > cell > subcellular structure
  4. Column 4:  Phenotypes and other measures
  5. Column 5:  Descriptions and comments
  6. Column 6:  Literature citations or other external references

Column mapping

NIF is providing both column and value mapping to enhance the semantic search and to pave the way for export of the NIF linked data graph.  The purpose of the column mapping is to set the ontological domain of the entities contained within.  Each of these domains generally corresponds to one of the NIFSTD modules:  organism, anatomical entity, cell, subcellular entity, molecule, function, disease, technique, resource.  We do not want to map the column at too granular level so as to avoid consistency problems with the contents.  At this point, we are also not mapping column roles.  So the fact that an organism serves as the subject of a study will not be reflected in the mapping:  any column containing an organism should be mapped to organism.  Similarly, even if a column contains brain parts, we will map to anatomical entity, to ensure that if the source later adds parts of the spinal cord or parts of the peripheral nervous system, that we will not be in conflict.  This policy may be revisited as the ontologies evolve.

Guidelines for entity mapping and linking data

NIF should facilitate interlinking of data, literature and tools wherever possible.  When any entity has a unique ID, NIF should provide the ID in its views.  The following practices should be implemented for all sources:

Rule #1:  All references to identifiers need to be bidirectional!!!!!!!!!!!!!

Rule #2:  Use of identifiers for external references

Form of Identifier:  Source:ID, e.g., PMID:000000000

Literature citations:  Where possible, add references as PMIDs to each record. When PMIDs not available, then use DOIs.

External database/data set reference:  Add database identifiers like DatabaseShortName:identifier (e.g., GEO:GSE12345)

Organism:  "Organism" is the preferred name for any column containing organism name, with the exception of human subjects where not deemed appropriate.  For any other organism terms such as species, animal, host, use organism (unless this is not sufficiently specific). Use the NCBI tax id as identifier. If the animal is a transgenic then add the identifier from the species specific database (e.g., MGI identifier).

Brain region:  For any brain region, use the NIFSTD label. 

Cell:  use an existing cell type listed in the NeuroLex

Protein:  For any protein, use PRO ids.

Small molecule: use ChEBI ids.

Gene:   Use Gene Symbol and Gene ID for Genes.  Gene name and probe identifier should not be used through the NIF interface, although they should be searchable through the view.

Annotation Standards

Current NIF annotation standards are maintained in the neurolex Wiki under NIF Annotation Standard

 

Dementia Severity

  • NIF is trying to develop reasonable interpretations of various assays and assessments
  • The Clinical Dementia Rating (CDR) is an assessment from 0 to 5, which is a standard used to assess the dementia of a patient (e.g. in Alzheimers disease).  The data are numerical, thus opaque to a search system, therefore NIF has discussed the issue with several clinicians who reluctantly gave us the following translation:
  • No dementia
  • CDR = 0
    • Semantic type: Dementia severity
    • NIF_ID:
    • Definition:  average, healthy
  •  Mild cognitive impairment
    • CDR = 0.5
    • Semantic type: 
    • NIF_ID:
    • Definition:  very mild impairment, may be similar to SNOMEDID: 407630006 term: Global Deterioration Scale (GDS) level 2 - very mild cognitive decline (finding), although this comes from a different assessment scale.
  • Mild dementia
    • CDR = 1
    • Semantic type: 
    • NIF_ID:
    • Definition:  mild impairment, but attributable to AD.  may be similar to SNOMEDID: 407631005 term: Global Deterioration Scale (GDS) level 3 - mild cognitive decline (finding), although this comes from a different assessment scale
  • Moderate dementia
    • CDR = 2
    • Semantic type: 
    • NIF_ID:
    • Definition:  impairment attributable to AD, may be similar to SNOMEDID: 407632003 term: Global Deterioration Scale (GDS) level 4 - moderate cognitive decline, although this comes from a different assessment scale.
  • Severe dementia
    • CDR = 3
    • Semantic type: 
    • NIF_ID:
    • Definition:  severe impairment attributable to AD, may be similar to SNOMEDID: 407634002 term: Global Deterioration Scale (GDS) level 6 - severe cognitive decline, although this comes from a different assessment scale.
  • No labels